Viemed Healthcare, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2024, reporting record performance. For Q4 2024, net revenues reached $57.1 million, marking a 15.4% increase from $49.5 million in Q4 2023. Net income for the quarter more than doubled to $2.5 million, up 108.3% from $1.2 million in the prior year.
Full-year 2024 net revenues totaled $230.2 million, a 15.2% increase over $199.8 million in 2023, while full-year net income grew by 102.2% to $9.1 million from $4.5 million. Adjusted EBITDA for the full year was $49.7 million, an increase of 17.4% compared to $42.3 million in 2023. The company also reported a 10.6% year-over-year increase in ventilator patients, reaching 11,500.
Looking ahead, Viemed issued its full-year 2025 guidance, projecting net revenue between $250 million and $260 million. Adjusted EBITDA for 2025 is forecasted to be in the range of $53 million to $56 million. CEO Casey Hoyt highlighted the momentum from sales force improvements and business diversification, expressing confidence in the company's value proposition in a regulatory environment favoring home care.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.